Lupin Pharmaceuticals Email Format

Pharmaceutical Manufacturing
10,001-25,000 employees
Mumbai, Maharashtra, India

Lupin Pharmaceuticals is a global pharmaceutical company headquartered in Mumbai, specializing in branded and generic formulations, complex generics, biotechnology products, and APIs across 100+ markets.

Find contacts at Lupin Pharmaceuticals

Search our verified sources for decision-makers, emails, and titles.

Start searching
VERIFIED BY CLAY

firstlast@lupin.com

Company Overview

Industry
Pharmaceutical Manufacturing
Founded
1968
Headquarters
Mumbai, Maharashtra, India
Revenue
$2.5B-$5B
FUNDING Stage
Public
Key Executives
Vinita Gupta (Chief Executive Officer), Ramesh Swaminathan (Executive Director, Global CFO, Head of IT and API Plus SBU), Christoph Funke (Chief Technical Operations Officer)

Tech Stack

Microsoft Azure

Cloud

Signup

to know

Signup

to know

Signup

to know

Key Executives

Chief Executive Officer

Find the current person →

Chief Finance Officer

Find the current person →

Chief Operating Officer

Find the current person →

Chief Technology Officer

Find the current person →

Chief Marketing Officer

Find the current person →

Chairman

Find the current person →

4.9/5 on G2
40K+ GTM professionals
SOC 2 Type II certified

Frequently Asked Questions

What is the email format of Lupin Pharmaceuticals?

Lupin Pharmaceuticals uses the firstlast format, so Jane Smith would be janesmith@lupin.com.

What therapeutic areas does Lupin Pharmaceuticals focus on in its U.S. specialty business?

Lupin Pharmaceuticals has built its U.S. specialty business around respiratory conditions, including asthma and COPD, with key products like Xopenex HFA. The broader portfolio also spans cardiovascular, diabetes, gastrointestinal, and women's health.

How many global markets does Lupin Pharmaceuticals operate in?

Lupin Pharmaceuticals operates across more than 100 global markets, with major presences in the United States, India, Japan, Europe, and Australia, and business segments covering generics, specialty, and biosimilars.

Which biosimilar products has Lupin Pharmaceuticals developed for immunology and oncology?

Lupin Pharmaceuticals has developed biosimilars including an etanercept product for rheumatoid arthritis and related conditions, a pegfilgrastim for oncology supportive care, and a ranibizumab biosimilar targeting retinal disorders.

Who leads Lupin Pharmaceuticals as CEO, and how large is the company?

Vinita Gupta serves as CEO of Lupin Pharmaceuticals, which employs approximately 21,805 people globally. Tools like Clay can help you find and verify the right contact within the organization for outreach.

Share Article

Get access to more people and company data using Clay

Leverage the power of 100+ data providers for industry-leading data coverage & quality.

4.9 rating

More Articles